Reportstack officials have announced a new market report on Changing Regulatory and Reimbursement Scenario for Medical Devices in the U.S. Market that looks at the regulatory landscape and reimbursement scenario in the US for four medical device markets: cardiovascular devices, neurostimulation devices, diagnostic imaging devices, and endoscopy devices.
The report provides comprehensive information on establishment registration, medical device listing, Premarket Notification (510k) or Premarket Approval (PMA), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, labeling requirements, and Medical Device Reporting (MDR). The report also reviews the reimbursement scenario in these medical device markets. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
The report analyzes the regulatory and reimbursement scenario for medical devices in the U.S.; information on the regulatory landscape in the U.S.: establishment registration, medical device listing, Premarket Notification (510k) or PMA, IDE for clinical studies, QS regulation, labeling requirements, and MDR, information on reimbursement coverage in the U.S. for cardiovascular devices, neurostimulation devices, diagnostic imaging devices, and endoscopy devices; annualized market revenue data, forecast to 2018, for the transcatheter heart valves market, left ventricular assist devices market, and endoscopy devices market; and qualitative analysis of key trends in the U.S. regulatory and reimbursement landscape.
To view the table of contents and know more details please visit Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market report.
Source: Reportstack.com